Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2010
11/04/2010CA2758740A1 Salt of abt-263 and solid-state forms thereof
11/04/2010CA2758596A1 Stabilized lipid formulation of apoptosis promoter
11/04/2010CA2758534A1 Lipid formulation of apoptosis promoter
11/04/2010CA2757761A1 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
11/04/2010CA2757757A1 Use of 1-phenyl-3-dimethylaminopropane compounds for treating rheumatoid pain
11/04/2010CA2750678A1 Isoxazole derivatives
11/04/2010CA2748892A1 A process for the isolation of carotenoids crystals from different plants
11/04/2010CA2747420A1 Azaazulene compounds
11/03/2010EP2246443A1 Antisense modulation of PTP1B expression
11/03/2010EP2246433A1 Concatamers for immune modulation
11/03/2010EP2246422A1 Polynucleotide or analogue thereof, and gene expression regulation method using the polynucleotide or the analogue thereof
11/03/2010EP2246363A1 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
11/03/2010EP2246354A1 Thieno[3,2-d]pyrimidine derivative useful as PI3K inhibitor
11/03/2010EP2246352A1 Novel diazabicyclic aryl derivatives and their medical use
11/03/2010EP2246349A1 Treatment of infectious diseases
11/03/2010EP2246347A1 Dicycloazaalkane derivates, preparation processes and medical uses thereof
11/03/2010EP2246346A1 Indolylmaleimide derivatives as protein kinase inhibitors
11/03/2010EP2246345A1 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
11/03/2010EP2246344A1 Pyrimidine compounds and medicinal composition thereof
11/03/2010EP2246339A1 Derivatives of benzothiazepine and their use as modulators of AMPA and NMDA receptors
11/03/2010EP2246338A1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition
11/03/2010EP2246337A1 Use of isoxazole derivatives as cyclooxygenase inhibitors
11/03/2010EP2246336A1 Fibrosis inhibitor
11/03/2010EP2246334A1 Medicinal composition for inhibiting amyloid- protein deposition
11/03/2010EP2246333A1 Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
11/03/2010EP2246332A1 Pyrazole derivatives as anti-francisella agents
11/03/2010EP2246331A1 NR2B-selective NMDA-receptor antagonists
11/03/2010EP2246329A1 4(1H)-pyridinone derivatives and their use as antimalaria agents
11/03/2010EP2246328A1 3'-Alkoxy spirocyclic tetronic acid derivatives
11/03/2010EP2246327A1 A process for isolation of lutein and zeaxanthin crystals from plant sources
11/03/2010EP2246321A1 Delayed release rasagiline formulation
11/03/2010EP2246069A1 Method of inhibiting cancer cell proliferation, proliferation inhibitor and screening method
11/03/2010EP2246066A1 Use of neurotoxin therapy for treatment of urologic and related disorders
11/03/2010EP2246062A1 Methods and compositions for emergency contraception using endothelin receptor antagonists
11/03/2010EP2246060A1 Liver function-protecting agent
11/03/2010EP2246059A1 Adhesive patch
11/03/2010EP2246058A1 Noribogaine in the treatment of pain and drug addiction
11/03/2010EP2246057A1 Use of allopurinol for the treatment of hand foot skin reaction
11/03/2010EP2246056A1 Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising the liposome preparation
11/03/2010EP2246055A1 The use of aryl piperazine derivatives in manufacturing medicants for treating pain
11/03/2010EP2246054A1 Fentanyl-containing patch for external use
11/03/2010EP2246053A1 Use of pramipexole to treat amyotrophic lateral sclerosis
11/03/2010EP2246052A1 Orally rapidly disintegrating tablet comprising imidafenacin
11/03/2010EP2246051A1 Method for production of orally rapidly disintegrating tablet comprising imidafenacin as active ingredient
11/03/2010EP2246050A1 Combination therapy comprising mechanical vibration for the treatment of a disease of the musculoskeletal or nervous system
11/03/2010EP2246049A2 Pharmaceutical composition and dosage forms for administration of hydrophobic drugs
11/03/2010EP2246048A1 Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis
11/03/2010EP2246047A1 Use of Lanostane derivatives in treating Cachexia
11/03/2010EP2246046A1 Orally disintegrating olanzapine tablet
11/03/2010EP2246045A1 Method for stabilizing phenylephrine
11/03/2010EP2246044A1 Paediatric solutions comprising a beta-blocker
11/03/2010EP2245166A1 Very long chain polyunsaturated fatty acids, methods of production, and uses
11/03/2010EP2245163A2 Cell populations for polypeptide analysis and uses of same
11/03/2010EP2245140A2 Compositions comprising hdac inhibitors and methods of their use in restoring stem cell function and preventing heart failure
11/03/2010EP2245042A1 C20-c21 substituted glucocorticoid receptor agonists
11/03/2010EP2245038A1 New macrolides and their use
11/03/2010EP2245037A2 Novel compounds and methods for therapy
11/03/2010EP2245033A1 Pyrrolopyrazine kinase inhibitors
11/03/2010EP2245032A1 Folates, compositions and uses thereof
11/03/2010EP2245031A2 6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions
11/03/2010EP2245030A1 Enantiomerically pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl)ethylamino]benzoic acid, its use in medical therapy, and a pharmaceutical composition comprising it - 026
11/03/2010EP2245029A1 Heterocyclic inhibitors of stearoyl-coa desaturase
11/03/2010EP2245028A1 5-aminocyclylmethyl-oxazolidin-2-one derivatives
11/03/2010EP2245027A1 Hepatitis c virus inhibitors
11/03/2010EP2245026A1 Spirocyclic heterocycles, medicaments containing said compounds, use thereof and method for their production
11/03/2010EP2245024A1 5-hydroxy-2-methyl-4h-pyran-4-one-esters as novel tyrosinase inhibitors
11/03/2010EP2245023A1 Heterocyclic antiviral compounds
11/03/2010EP2245020A2 Thiazolylidine urea and amide derivatives and methods of use thereof
11/03/2010EP2245019A1 4, 5-dihydro-oxazol-2-yl amine derivatives
11/03/2010EP2245017A2 Novel heterocycles
11/03/2010EP2245016A1 Substituted amino-benzimidazoles, medicaments comprising said compound, their use and their method of manufacture
11/03/2010EP2245015A1 Difluorinated tripeptides as hcv serine protease inhibitors
11/03/2010EP2245014A1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
11/03/2010EP2245012A1 Inhibitors of p38 map kinase
11/03/2010EP2245011A1 Novel piperidine-4-carboxylic acid phenyl-alkyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11/03/2010EP2245010A1 Indoles active on crth2 receptor
11/03/2010EP2245009A2 Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives
11/03/2010EP2245007A1 Novel crystalline forms
11/03/2010EP2245006A1 Sulfonamides as orexin antagonists
11/03/2010EP2245005A1 Substituted cyclopentanes having prostaglandin activity
11/03/2010EP2244998A2 Elansolids, novel natural metabolites of flexibacter and antibiotically active derivatives thereof
11/03/2010EP2244789A2 Combination of metformin and an mtp inhibitor
11/03/2010EP2244737A1 Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief
11/03/2010EP2244714A1 Use of picoplatin and bevacizumab to treat colorectal cancer
11/03/2010EP2244713A1 Use of a gamma-secretase inhibitor for treating cancer
11/03/2010EP2244712A1 In vivo studies of crystalline forms of meloxicam
11/03/2010EP2244711A1 Certain chemical entities, compositions and methods
11/03/2010EP2244710A1 A method of administering a pde3 inhibitor via titration for the treatment of peripheral arterial disease
11/03/2010EP2244709A2 Topical formulations for the treatment of psoriasis
11/03/2010EP2244708A1 NEW 2,3,4,5-TEtRAHYDRO-1H-PYRIDO [4,3-B] INDOLE COMPOUNDS AND METHODS OF USE THEREOF
11/03/2010EP2244707A1 Tetrahydrocyclopentaýc¨acridine derivatives as kinase inhibitors and biological applications thereof
11/03/2010EP2244706A1 Glucokinase activators
11/03/2010EP2244705A1 Novel crystalline forms of 4- [4- (2-adamantylcarbam0yl) -5-tert-butyl-pyrazol-1-yl]benzoic acid
11/03/2010EP2244704A1 Treatment of aspirin resistance with betaine and/or betaine enriched molasses
11/03/2010EP2244703A1 Pharmaceuticals and the production and use thereof in the treatment of painful neuropathies
11/03/2010EP2244702A1 Treatment of neural diseases or conditions
11/03/2010EP2244701A2 Corroles for neuroprotection and neurorescue
11/03/2010EP2244700A1 Stromal interacting molecule knockout mouse and uses thereof
11/03/2010EP2244698A1 Biodegradable therapeutic nanoparticles containing an antimicrobial agent
11/03/2010EP2244693A1 Agent for intra-articular injection
1 ... 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 ... 7860